Michelle Childs

Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action Introduction The Drugs for Neglected Diseases initiative (DNDi) is committed to maximising the scientific value of the individual participant data (IPD) it has collected during its 20 years of activit...

How can individual participant data from clinical trials be shared to advance scientific research into unmet needs while safeguarding participants’ privacy? Its challenging. In this BMJ article we describe how DNDI seeks to do so and a call for action.
bmjopen.bmj.com/content/14/1...

Integrating Equity Into Licensing Agreements For Taxpayer-Funded Technologies | Health Affairs Forefront Current National Institutes of Health (NIH) policy allows corporations to commercialize medical technologies with few safeguards for global access. A new draft NIH policy begins to address that, but t...

NIH, the largest R&D funder in the world, is considering a new policy on global access to some publicly funded #health technologies. This policy must include guarantees for affordability, availability, tech transfer, transparency & open knowledge-sharing. Read more: shorturl.at/NxV6R
#HealthAffairs